A 10-year-old girl initially presented at an outside institution with right hip and knee pain. At that time, the patient and her family were told that her hip and knee x-rays were normal. The pain continued, and MRI of the hip without contrast was performed at the outside institution approximately nine months after initial presentation. This study revealed a focal, well-defined lesion that was hypointense on both the T1 and STIR sequences, with edema in the adjacent bone and soft tissues (Fig. 1) . The patient was then referred to our institution for evaluation and treatment.
We present a case of subperiosteal recurrence of chondroblastoma adjacent to the greater trochanter that was initially thought to represent septic arthritis of the hip in a 10-year-old girl. Soft-tissue recurrence of chondroblastoma is very rare, with fewer than ten cases reported in the literature. We demonstrate the recurrence on both CT and MRI. The MRI clearly demonstrates the soft-tissue recurrence and the associated inflammatory changes, with signal characteristics not unlike the primary tumor. , and (C) axial postgadolinium fat-saturated T1 (TR 566/TE 13) MR images of the right hip. Enlarging relatively hypointense T2 and T1 lesion (arrows) in the soft tissues posteromedial to the greater trochanter, with an associated joint effusion and inflammatory changes in the soft tissues and bone. Postgadolinium, the lesion demonstrates enhancement that is less intense than the surrounding inflammatory changes in soft tissues and bone.
The patient continued with pain and inability to bear weight, despite aggressive physical therapy. A repeat MRI was performed and revealed intense increased signal on fatsaturated T2-weighted and on postcontrast fat-saturated T1-weighted images throughout the soft tissues around the right hip. Embedded in this inflammatory edematous reaction was an oval, 3-cm mass posteromedial to the greater trochanter that enhanced less than the surrounding tissue and therefore was visible as an island of relatively low signal (Fig. 5) . The patient was taken to the operating room for an open biopsy. The tumor was identified in a subperiosteal location outside of the cortical bone. The frozen section was consistent with recurrent chondroblastoma. Therefore, the surgeon proceeded to excise the soft-tissue mass and perform a curettage and bone-grafting of the surface of the bone. Final pathology confirmed recurrent chondroblastoma. The histological appearance was similar to the original tumor. It was composed of a diffuse proliferation of mononuclear cells with intermixed multinuclear giant cells and scattered foci of chondroid matrix, some of which had undergone calcification (Fig. 6 ). At followup eight months after surgery, the patient was pain-free and fully ambulatory.
Discussion
Chondroblastoma is a rare benign bone tumor accounting for approximately 1% of all benign bone tumors (1). The lesion typically presents as a well-demarcated lytic lesion in the epiphysis on radiographs. They are also wellknown to occur in the apophyses, including the greater trochanter. Treatment consists of curettage and filling of the defect with either bone graft or methylmethacrylate. Recurrence rates range from 8.3% to 21.4% in the more recent literature (2-5). The single most important factor predictive of recurrence is retention of tumor material at surgery (2, 3). Lesions occurring in the region of the proximal femur and pelvis also demonstrate an increased rate of recurrence (2, 5). The reason for this higher rate of recurrence may be secondary to difficulty of curettage in this location. Given the location of our patient's lesion, our patient was at an increased risk for recurrence. Biological aggressiveness of the tumor may also play a role in recurrence (2). In our patient, there was no evidence for aggressive features either in the primary tumor or recurrent tumor.
Soft-tissue recurrence of chondroblastoma has been reported, although it is rare. The first case was reported in 1966 (6). To our knowledge, a total of eight soft-tissue recurrences have been reported in the literature (6) (7) (8) (9) (10) (11) . Our patient presented with subperiosteal recurrence of tumor along the posteromedial aspect of the greater trochanter. Therefore, the plain films of the hip were not particularly helpful, as there was no osteolysis to suggest tumor recurrence. On the CT performed at the time of the second biopsy, the soft-tissue mass surrounded by a thin periosteal shell remained unrecognized but was similar in appearance to a reported case of primary cortical chondroblastoma (12) . The MRI in this case clearly depicted the recurrence and surrounding inflammatory change. The low-tointermediate T2-signal intensity and lobular margin used to describe primary chondroblastoma was also present in our case of subperiosteal recurrence (13) .
Our patient presented with significant edema within the adjacent soft tissues and bone marrow, a finding that is also common in primary chondroblastoma (13, 14) . In fact, the surrounding inflammatory reaction can be used as sign of recurrence, as the inflammatory change resolves after removal of a lesion (14) . In our case, the initial MRI after the return of the patient's symptoms was thought to represent septic arthritis, given the extensive marrow and soft-tissue edema, and joint effusion. Although infection was a reasonable consideration, had the recurrent mass in the soft tissues been recognized, this might have allowed more timely initiation of definitive treatment. To our knowledge, this is the first case report of an MRI demonstrating subperiosteal recurrence of chondroblastoma.
In summary, persistent or increasing inflammatory changes on MRI in a patient with previous removal of a chondroblastoma should lead to a careful search for recurrent tumor. Although this typically occurs in bone, it may on occasion also develop in soft tissue, which can be subtler and harder to recognize. 
